Keybanc analyst John Vinh maintains Ambarella (NASDAQ:AMBA) with a Overweight and raises the price target from $95 to $105.
Keybanc Maintains Overweight on Ambarella, Raises Price Target to $105
Keybanc analyst John Vinh maintains Ambarella (NASDAQ:AMBA) with a Overweight and raises the price target from $95 to $105.
Related Posts
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Camber Energy Terminates All Warrants In Favor Of Discover & Antilles
Camber Energy, Inc. (NYSE:CEI) ("Camber" or the "Company") today announced that on April 25, 2023 the Company entered into agreements (collectively, the "Termination Agreements")
KnowBe4 Earlier Reported Q2 EPS $0.07 Beats $0.02 Estimate, Sales $80.76M Beat $79.41M Estimate
KnowBe4 (NASDAQ:KNBE) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.02 by 250 percent. This is a 250 percent increase over earnings of $0.02 per share from the same period